Nephrology

DocGo's Subsidiary Ambulnz Launches Service in Wisconsin

Retrieved on: 
Thursday, April 22, 2021
Medicine, Clinical medicine, Membrane technology, Renal dialysis, Detoxification, Dialysis, Nephrology

The company\'sproprietary artificial intelligence (AI) technology provides intelligent fleet routing, accurate ETAs, and real-time vehicle GPS tracking for enhanced patient engagement and peace of mind.

Key Points: 
  • The company\'sproprietary artificial intelligence (AI) technology provides intelligent fleet routing, accurate ETAs, and real-time vehicle GPS tracking for enhanced patient engagement and peace of mind.
  • Dialysis patients in Wisconsin using Ambulnz services can now get dedicated and reliable transportation to and from their kidney dialysis appointments.\n"The expansion into Wisconsin demonstrates our ongoing contribution to transforming the patient experience.
  • Ambulnz is now is helping patients get to where they need to be, when they need to be there, in order to improve their quality of life.
  • Together with DocGo\'s integrated Ambulnz medical transport services, DocGo is bridging the gap between physical and virtual care.

Outlook on the End Stage Renal Disease Global Market to 2025 - Competitive Analysis and Impact of COVID-19

Retrieved on: 
Tuesday, April 13, 2021
Medical specialties, Anatomy, Medicine, Kidney diseases, Organ failure, Nephrology, Membrane technology, Chronic kidney disease, Dialysis, Kidney failure, Kidney transplantation, Kidney disease

The ongoing Covid-19 pandemic has resulted in an increased demand for home dialysis across the globe.\nThe Global End Stage Renal Disease Market is segmented further based on Disease Type, Treatment Type, End User, and Geography.\nBy Disease Type, the market is classified as Chronic Kidney Disease and End stage renal disease.\nBy Treatment, the market is classified as Dialysis, Medication and kidney transplantation.

Key Points: 
  • The ongoing Covid-19 pandemic has resulted in an increased demand for home dialysis across the globe.\nThe Global End Stage Renal Disease Market is segmented further based on Disease Type, Treatment Type, End User, and Geography.\nBy Disease Type, the market is classified as Chronic Kidney Disease and End stage renal disease.\nBy Treatment, the market is classified as Dialysis, Medication and kidney transplantation.
  • Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.\nThe report offers a comprehensive evaluation of the Global End Stage Renal Disease Market.
  • The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size.
  • The impact of Covid-19 on the market is also featured in the report.\nThe report also contains the competitive analysis using IGR Competitive Quadrant, the analyst's proprietary competitive positioning tool.\nA complete analysis of the market, including parent industry\n"

Monogram Health Appoints Former CMS Administrator Seema Verma to Board of Directors

Retrieved on: 
Monday, April 12, 2021
Healthcare reform in the United States, Federal assistance in the United States, Presidency of Lyndon B. Johnson, Seema Verma, White House Coronavirus Task Force, Centers for Medicare & Medicaid Services, Health, Dialysis, Seema, Nephrology, Medicare, Medicaid

b'NASHVILLE, Tenn., April 12, 2021 /PRNewswire/ -- Monogram Health today announced the appointment of Seema Verma, MPH, to its board of directors.

Key Points: 
  • b'NASHVILLE, Tenn., April 12, 2021 /PRNewswire/ -- Monogram Health today announced the appointment of Seema Verma, MPH, to its board of directors.
  • Verma, former administrator for the Centers for Medicare and Medicaid Services (CMS), joins the board as Monogram continues to expand its national footprint to transform care for kidney disease patients across the U.S.\n"We are delighted to welcome Seema Verma to our board as an independent director.
  • "\nA leading expert on health policy and value-based care, Verma was the longest-tenured administrator of CMS in modern history.
  • Partnering with health plans, physician practices, dialysis providers and clinically integrated health systems, Monogram Health provides patients with exceptional at-home individualized care management and Nephrology care delivery.

Ardelyx Announces Upcoming Data Presentation at ISN World Congress of Nephrology 2021

Retrieved on: 
Monday, April 12, 2021
Potassium, Medical specialties, Chemistry, Medicine, Nephrology, Hyperkalemia, Metabolic acidosis, Dialysis, Prescription Drug User Fee Act, Potassium in biology, Roxadustat

Ardelyx is advancing tenapanor, a novel product candidate to control serum phosphorus in adult patients with CKD on dialysis, for which the company's NDA is currently under review by the FDA, with a PDUFA date of April 29, 2021.

Key Points: 
  • Ardelyx is advancing tenapanor, a novel product candidate to control serum phosphorus in adult patients with CKD on dialysis, for which the company's NDA is currently under review by the FDA, with a PDUFA date of April 29, 2021.
  • Ardelyx is also advancing RDX013, a potassium secretagogue, for the potential treatment of elevated serum potassium, or hyperkalemia, a problem among certain patients with kidney and/or heart disease and has an early-stage program in metabolic acidosis, a serious electrolyte disorder in patients with CKD.
  • In addition, Ardelyx received FDA approval of IBSRELA (tenapanor) on September 12, 2019.
  • Ardelyx has established agreements with Kyowa Kirin in Japan, Fosun Pharma in China and Knight Therapeutics in Canada for the development and commercialization of tenapanor in their respective territories.\nView original content to download multimedia: http://www.prnewswire.com/news-releases/ardelyx-announces-upcoming-data-...\n"

Outset Medical Named a Winner in Round 2 of the KidneyX COVID-19 Kidney Care Challenge

Retrieved on: 
Friday, April 9, 2021
Software, Managed care, Health, Medical devices, Data management, Infectious diseases, Hospitals, Technology, Medicine, Membrane technology, Clinical medicine, Medical specialties, Dialysis, Nephrology, Hemodialysis, Kidney, Outset Medical, Inc., KidneyX, the U.S. Department of Health and Human Services, the American Society of Nephrology

The U.S. Department of Health and Human Services (HHS) and the American Society of Nephrology (ASN) have named Outset Medicals Tablo Hemodialysis System one of seven winners in Round 2 of the KidneyX COVID-19 Kidney Care Challenge , recognizing innovative solutions for safely delivering kidney care during the pandemic.

Key Points: 
  • The U.S. Department of Health and Human Services (HHS) and the American Society of Nephrology (ASN) have named Outset Medicals Tablo Hemodialysis System one of seven winners in Round 2 of the KidneyX COVID-19 Kidney Care Challenge , recognizing innovative solutions for safely delivering kidney care during the pandemic.
  • The KidneyX COVID-19 Kidney Care Challenge recognizes solutions that reduce the transmission of the coronavirus among people with kidney diseases and/or reduce the risk of kidney damage among people who contract the virus.
  • With a total prize pool of $300,000, the KidneyX COVID-19 Kidney Care Challenge aims to share processes, systems, best practices and tools with frontline communities.
  • KidneyX seeks to improve the lives of people with kidney disease by expediting the development of drugs, devices, biologics, and other therapies across the spectrum of kidney care.

Global Dialysis Market Insights & Forecasts Report 2020-2024 - Rising Demand for Home Dialysis / Favorable Reimbursement Structure / Technological Advancements - ResearchAndMarkets.com

Retrieved on: 
Thursday, April 8, 2021
Managed care, Health, Medicine, Clinical medicine, Renal dialysis, Membrane technology, Nephrology, Hemodialysis, Dialysis, Home hemodialysis, Peritoneal dialysis, Northwest Kidney Centers, End Stage Renal Disease Program

The "Global Dialysis Market: Insights & Forecast with Potential Impact of COVID-19 (2020-2024)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Dialysis Market: Insights & Forecast with Potential Impact of COVID-19 (2020-2024)" report has been added to ResearchAndMarkets.com's offering.
  • A few notable trends include rising demand for home dialysis, favorable reimbursement structure, technological advancements and preference of dialysis treatment over the transplant.
  • The global dialysis market is highly dominated by hemodialysis owing to a preference for dialysis treatment over transplant, rising prevalence of kidney diseases and a rising number of dialysis centers.
  • The report provides a comprehensive analysis of the global dialysis market, segmented into hemodialysis and peritoneal dialysis.

Innovative Renal Care Acquires Kidney Treatment Center of San Antonio

Retrieved on: 
Tuesday, April 6, 2021
General Health, Health, Other Health, Medicine, Membrane technology, Clinical medicine, Medical specialties, Detoxification, Dialysis, Kidney, Nephrology, Renal dialysis, Northwest Kidney Centers, Artificial kidney, Innovative Renal Care, Kidney Treatment Center San Antonio

Innovative Renal Care (IRC), a brand of American Renal Associates (ARA), announced today its acquisition of the assets of Kidney Treatment Center of San Antonio (KTC), an independently owned and operated patient-centered renal dialysis company offering highly personalized care to patients across three dialysis centers in San Antonio.

Key Points: 
  • Innovative Renal Care (IRC), a brand of American Renal Associates (ARA), announced today its acquisition of the assets of Kidney Treatment Center of San Antonio (KTC), an independently owned and operated patient-centered renal dialysis company offering highly personalized care to patients across three dialysis centers in San Antonio.
  • The three clinics, which are currently accepting new patients, will be renamed as IRC San Antonio - Medical Drive, IRC San Antonio - Castroville Road and IRC San Antonio - South New Braunfels.
  • Innovative Renal Care (IRC), an ARA brand, is a pioneering network of dialysis professionals devoted to helping people with kidney disease lead their best lives as they undergo treatment.
  • Our three Kidney Treatment Centers offer a variety of services to patients with end stage renal disease.

Monogram Health Opens Operations Hub in Arizona

Retrieved on: 
Tuesday, April 6, 2021
Nephrology, Dialysis, Kidney, Branches of biology, Medicine, Health care

TEMPE, Ariz., April 6, 2021 /PRNewswire/ -- Monogram Health , a managed services company transforming care for individuals with chronic kidney and end-stage renal disease, has opened an operations hub in Tempe, Arizona, to support its growing patient base in the Western U.S. and nationwide.

Key Points: 
  • TEMPE, Ariz., April 6, 2021 /PRNewswire/ -- Monogram Health , a managed services company transforming care for individuals with chronic kidney and end-stage renal disease, has opened an operations hub in Tempe, Arizona, to support its growing patient base in the Western U.S. and nationwide.
  • "Our new operations hub ensures we have the right resources in the right location to deliver seamless support to our clients and caregivers throughout the country."
  • The recent partnerships add to the company's existing client base, including Banner University Health Plans in Arizona.
  • Partnering with health plans, physician practices, dialysis providers and clinically integrated health systems, Monogram Health provides patients with exceptional at-home individualized care management and Nephrology care delivery.

Home Dialysis Nurse to Receive National Kidney Foundation's Top Nursing Award

Retrieved on: 
Tuesday, April 6, 2021
Anatomy, Medicine, Kidney diseases, Health care, National Kidney Foundation, Nephrology, Organ failure, Kidney disease, Kidney failure, National Kidney Foundation Singapore

When I see my patients, they are learning about kidney failure, a diagnosis that is life-long, so they need hope.

Key Points: 
  • When I see my patients, they are learning about kidney failure, a diagnosis that is life-long, so they need hope.
  • Ms. DeClaro has been a registered nurse at Fresenius Kidney Care for more than 20 years.
  • Hispanic or Latino people are 1.3 times more likely than non-Hispanic or non-Latino people to have kidney failure.
  • The National Kidney Foundation (NKF) is the largest, most comprehensive, and longstanding patient-centric organization dedicated to the awareness, prevention, and treatment of kidney disease in the U.S. For more information about NKF, visit www.kidney.org .

National Kidney Foundation Recognizes Illinois Nephrologist with Distinguished Service Award

Retrieved on: 
Wednesday, March 31, 2021
National Kidney Foundation, NKF, Nephrology, Health care, Medicine, Health, National Kidney Foundation Singapore, T. T. Durai

NEW YORK, March 31, 2021 /PRNewswire/ --Each year the National Kidney Foundation (NKF) highlights the work of one of thousands of kidney health professionals for their community service and educational activities in promoting NKF's mission on a local level and presents that person with the Medical Advisory Board Distinguished Service Award.

Key Points: 
  • NEW YORK, March 31, 2021 /PRNewswire/ --Each year the National Kidney Foundation (NKF) highlights the work of one of thousands of kidney health professionals for their community service and educational activities in promoting NKF's mission on a local level and presents that person with the Medical Advisory Board Distinguished Service Award.
  • Dr. Ahya is the Chairperson of the Professional Advisory Board of the National Kidney Foundation of Illinois and helps plan the professional programming including Citywide Grand Rounds and the annual Controversies in Nephrology.
  • "Dr. Ahya is a leader in community service in Illinois and on the frontline of the National Kidney Foundation," said Dr. Paul Palevsky, President of the National Kidney Foundation.
  • The National Kidney Foundation (NKF) is the largest, most comprehensive, and longstanding patient-centric organization dedicated to the awareness, prevention, and treatment of kidney disease in the U.S. For more information about NKF, visit www.kidney.org .